بدائل البحث:
significant case » significant cause (توسيع البحث), significant based (توسيع البحث), significant change (توسيع البحث)
significant teer » significant gender (توسيع البحث), significant genes (توسيع البحث), significant trend (توسيع البحث)
teer decrease » mean decrease (توسيع البحث), greater decrease (توسيع البحث)
case based » made based (توسيع البحث), game based (توسيع البحث), rate based (توسيع البحث)
significant case » significant cause (توسيع البحث), significant based (توسيع البحث), significant change (توسيع البحث)
significant teer » significant gender (توسيع البحث), significant genes (توسيع البحث), significant trend (توسيع البحث)
teer decrease » mean decrease (توسيع البحث), greater decrease (توسيع البحث)
case based » made based (توسيع البحث), game based (توسيع البحث), rate based (توسيع البحث)
-
21
-
22
-
23
-
24
-
25
-
26
-
27
Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers.
منشور في 2024"…<p>(<b>A)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on days 1–22. (<b>B)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on day 22. …"
-
28
-
29
-
30
Deterministic result of the base-case analysis.
منشور في 2024"…Efficacy data and baseline characteristics in the base-case analysis were primarily derived from the 11-year results of the HERA trial. …"
-
31
-
32
-
33
-
34
-
35
The effect of HA digestion and HA replenishment alone or with CS on barrier function measured by TEER.
منشور في 2025"…PS decreased TEER. (C) Different treatments (treatment groups n = 8)with HA and/or CS did not affect TEER recovery after PS treatment, full recovery was seen in all groups after 24 hours. …"
-
36
-
37
The base case analysis.
منشور في 2025"…</p><p>Results</p><p>In the base-case scenario, adding benmelstobart and anlotinib to chemotherapy increased QALYs by 0.34 at an additional cost of $24,684.07, yielding an ICER of $71,559.84 per QALY. …"
-
38
-
39
Base-case results.
منشور في 2025"…One-way and probabilistic sensitivity analyses were conducted to estimate the robustness of the model results,</p><p>Results</p><p>In base-case analysis, compared with toripalimab plus chemotherapy and chemotherapy alone, ITH-testing directed therapy could bring additional 0.14 QALYs and 0.29 QALYs, with marginal costs of $3750.75 and $7778.18, resulting in the ICER of $27,353.27/QALY and $26,461.46/QALY, respectively, which lower than the Chinese willingness-to-pay (WTP) threshold. …"
-
40